Ridge Diagnostics, a San Diego-based neurodiagnostic company offering the first blood test for depression, is proud to announce that its depression blood test biomarker technology, MDDScore, was featured as part of the cover story in Psychiatric Times, August 2011, Volume XXVIII, No 8.
The story, "Blood Tests for Diagnosis of Schizophrenia and Depression?" was based on clinical research reported at the 164th American Psychiatric Association Annual Meeting held in Honolulu, HI, May 14-18, 2011. The article presented three companies and technologies.
In a quotation from the article, Lonna J. Williams, CEO of Ridge stated, "By having a biological indication of depression, patients and their families have a better understanding of the condition as a medical one, which reduces the stigma of mental health disorders and leads to an improvement in treatment compliance."
A simple blood test may also greatly assist primary care physicians in distinguishing Major Depressive Disorder from other conditions with over lapping symptoms, like fatigue and energy loss.
Ridge offers a proprietary, simple blood test for Major Depressive Disorder (MDD) through its CLIA-certified laboratory. Ridge researches, develops, and brings to healthcare providers and patients a blood test based on biological markers and diagnostic algorithms to aid in with the diagnosis of MDD and other neuropsychiatric disorders.